Fig. 3From: A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in EgyptSitagliptin associated increase in diabetic complications costs over 3-year horizon. MI myocardial infarction, CV cardiovascularBack to article page